Results 1 to 10 of about 156,497 (302)

Editorial: Developing combined modality therapy with mitochondria-targeting strategy [PDF]

Frontiers in Oncology, 2023
Yong Teng, Yong Teng
doaj   +2 more sources

Recent advances in combined modality therapy. [PDF]

Oncologist, 2010
Abstract Combined modality therapy emerged from preclinical data showing that carefully chosen drugs could enhance the sensitivity of tumor cells to radiation while having nonoverlapping toxicities. Recent advances in molecular biology involving the identification of cellular receptors, enzymes, and pathways involved in tumor growth and ...
Mierzwa ML, Nyati MK, Morgan MA, Lawrence TS.   +3 more
europepmc   +5 more sources

Delayed cerebral pseudoaneurysm following surgical and combined-modality therapy for glioblastoma multiforme: illustrative case. [PDF]

J Neurosurg Case Lessons, 2022
Krishnakumar HN, Son C.
europepmc   +3 more sources

Case Report: Effective management of residual glioblastoma with combined modality therapy [PDF]

Frontiers in Oncology
Glioblastoma (GBM) is an aggressive primary brain tumor with a poor prognosis, often characterized by rapid progression and resistance to conventional therapies.
Heng-Jui Chang, Chiao-Hsu Ke, Yu-Shan Wang, Yu-Shan Wang, Yu-Cheng Kuo, Yu-Cheng Kuo   +5 more
doaj   +2 more sources

Fifteen-Year Experience of a Single Institution: Outcomes for Early-Stage Hodgkins Lymphoma Comparing Chemotherapy Alone Versus Combined Modality Therapy. [PDF]

Adv Radiat Oncol
Qian JY, Amin R, Ali H, Cao Y, Switchenko JM, Rashid AS, Allen PB, Hanasoge S, Khan MK.   +8 more
europepmc   +3 more sources

Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma. [PDF]

JAMA Oncol, 2019
Jhawar SR, Rivera-Núñez Z, Drachtman R, Cole PD, Hoppe BS, Parikh RR.   +5 more
europepmc   +2 more sources

Combined modality therapy for exsudative form of age-related macular degeneration

Biomedical Photonics, 2013
Treatment outcomes in patients with age-related vascular degeneration due to formation of subretinal neovascular membrane (SNM) of two groups: photodynamic therapy (PDT) with Photosens alone (18 patients) and in combination with anti-VEGF therapy with ...
М. V. Budzinskaya, I. V. Gurova, I. V. Schegoleva, V. B. Loschenov, S. А. Shevchik, S. G. Kuzjmin, G. N. Vorogtsov   +6 more
doaj   +3 more sources

The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. [PDF]

Leuk Lymphoma, 2021
Augustyn A, Medeiros LJ, Ludmir EB, Gunther J, Fang P, Li S, Ok CY, Bankston ME, Verma V, Pasalic D, Ahmed S, Nastoupil LJ, Westin JR, Strati P, Neelapu SS, Nair R, Steiner RE, Iyer SP, Rodriguez A, Fayad LE, Flowers CR, Dabaja BS, Pinnix CC.   +22 more
europepmc   +3 more sources

Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone? [PDF]

Br J Haematol, 2017
Milgrom SA, Pinnix CC, Chuang H, Oki Y, Akhtari M, Mawlawi O, Garg N, Gunther JR, Reddy JP, Smith GL, Rohren E, Hagemeister FB, Lee HJ, Fayad LE, Dong W, Osborne EM, Abou Yehia Z, Fanale M, Dabaja BS.   +18 more
europepmc   +3 more sources

Management of Locally Advanced Esophageal Cancer

Journal of Nepal Medical Association, 2021
Esophageal cancer is diagnosed usually at a locally advanced stage. Surgery alone has less optimal results and a multimodality approach has been established as the standard of care for cII-III stages of esophageal cancer.
Binay Thakur, Mukti Devkota, Manish Chaudhary   +2 more
doaj   +3 more sources